¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ°ú¹Î¼º¹æ±¤ ÇÑÀÇ¿ø ÁÖ¸»Áø·á

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 

#ÀÎõ°ú¹Î¼º¹æ±¤, #ÀÎõ°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø, #¹æ±¤¿°, #ÀÎõ¹æ±¤¿°, #°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø, #¹æ±¤¿°ÇÑÀÇ¿ø, #ÀÎõ¹æ±¤¿°, #±¸¿ùµ¿°ú¹Î¼º¹æ±¤ 

 

 

ÀÎõ°ú¹Î¼º¹æ±¤,,ÀÎõ°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø,,¹æ±¤¿°,,ÀÎõ¹æ±¤¿°,,°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø,,¹æ±¤¿°ÇÑÀÇ¿ø,,ÀÎõ¹æ±¤¿°,,±¸¿ùµ¿°ú¹Î¼º¹æ±¤

¾È³çÇϼ¼¿ä. ÀÎõ°ú¹Î¼º¹æ±¤ ±¸¿ùµ¿ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä

 

 

ÀÎõ°ú¹Î¼º¹æ±¤ ±¸¿ùµ¿ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â¹æ±¤¿°, °£Áú¼º¹æ±¤, ¼ºÀξߴ¢Áõ, ¹æ±¤¿°Ä¡·á, ¾ß´¢Áõ, ÀÜ´¢°¨, ¿©Àڹ汤¿°Áõ»ó, °£Áú¼º¹æ±¤¿°, ³²ÀÚÀÜ´¢°¨, ºÓÀº¼Òº¯, ¿©¼ºÀÜ´¢°¨, ¼Òº¯Ç÷´¢, ³²Àڹ汤¿°, Áú¿°ÀÜ´¢°¨, ¾î¸°ÀÌ¿ÀÁܼÒÅÂ, ÀÓ½ÅÁß¿ÀÁܼÒÅÂ, ¿ä½Ç±Ý, ¼Ò¾Æ¹æ±¤¿°, Àý¹Ú´¢, °ú¹Î¼º¹æ±¤, ¿©Àڹ财Åë, ºó´¢, Àü¸³¼±, ¹æ±¤¿°¼Òº¯, ¸¸¼º¹æ±¤¿°µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù.

 

 

¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó Àδ밭ȭ, ¼ÒÇÕÇâ¿ø, ¿Â¿­Ä¡·á, ¸¶»çÁö, ±ÙÀ̿Ͼàħ, ¾îÇ÷¾àħ, ¸Å¼±¿ä¹ý, µµÀο¿ä¹ý, ÁßdzÁ¶±â°ËÁø, Çâ±â¿ä¹ý, ´Ü¼ø¿îµ¿Ä¡·á, ½½¸µ, ·Ñ¸µ, ³Ã¿Â¿å, mechanical therapy, paraffin, Àü±âÀÚ±ØÄ¡·á, Çdz»Ä§, ü¿­Áø´Ü±â, ¾Æ·Î¸¶Å׶óÇÇ, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù

 

 

¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç ºÎ»ê »çÇϱ¸ ´Ù´ë1µ¿, Àü³² ¿©¼ö½Ã °øÈ­µ¿, ¿ï»ê ºÏ±¸ »êÇϵ¿, Àü³² ±¸·Ê±º ±¤ÀǸé, °æ³² ÀǷɱº Ä¥°î¸é, ÀüºÏ ÀÍ»ê½Ã ÆȺÀµ¿, ÀÎõ °è¾ç±¸ µ¿¾çµ¿, ºÎ»ê ±ÝÁ¤±¸ ȸµ¿µ¿, °æ±â ¾È¼º½Ã ¼­Àε¿, °æ³² ±èÇؽà ¾î¹æµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ »ó³²µ¿, ºÎ»ê ¿µµµ±¸ ¿µ¼±µ¿3°¡, ÃæºÏ ÃæÁֽà ÁÖ´öÀ¾, °æºÏ ¹®°æ½Ã »ê¾ç¸é, Àü³² ¸ñÆ÷½Ã ÃøÈĵ¿, °æ³² °ÅÁ¦½Ã °ÅÁ¦¸é, ¿ï»ê Áß±¸ ¿Á±³µ¿, °­¿ø °­¸ª½Ã ȸ»êµ¿, Àü³² ¸ñÆ÷½Ã Ãູµ¿1°¡, °æ±â ¾È¼º½Ã ±Ý¼®µ¿, ºÎ»ê ºÏ±¸ È­¸íµ¿, Àü³² ³ªÁֽà »ï¿µµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ¼ºÈ£µ¿, °­¿ø ö¿ø±º ±Ù³²¸é, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¼®¼ö3µ¿, Àü³² ¿µ±¤±º ´ë¸¶¸é, °æ³² »çõ½Ã À̱ݵ¿, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ »ïõµ¿2°¡, ¿ï»ê ºÏ±¸ ´Þõµ¿, ÀÎõ °­È­±º ¾ç»ç¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù

 

 

ÀÎõ°ú¹Î¼º¹æ±¤Ä¡·á ãÀ¸½Ã´Â ÀÎõ³íÇöµ¿, ¹è°ð½Åµµ½Ã, ûÇе¿, ¿ëÇöµ¿, µ¿ÀÎõ, ¼þÀǵ¿, À²¸ñµ¿, °è¾ç±¸, ¿ëÀ¯µµ, °¡Á¤µ¿, °£¼®µ¿, ³íÇö°íÀܵ¿, ¼Û¸²µ¿, ºÎõ, µ¿±¸, Áßµ¿, °ü±³µ¿, Á־ȿª, °Ë¾Ï, ¿µÁ¾Çϴõµ½Ã, ¼Ò·¡Æ÷±¸, ³²µ¿±¸, °¡Áµ¿, ºñºÀ¸é, µµ¸²µ¿, ÀÎõÁÖ¾È, ³²¾çÀ¾, ¹®Çе¿, ÀÎõ, ¼±Çе¿, ÀÎõ³íÇö, ¹è°ð, ±¸¿ùµ¿, ¼Ûµµ±¹Á¦µµ½Ã, Áß±¸ µî ÀÎõ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù.

 

´õ »ìÆ캸±â

 

1. Gammie A, Kaper M, Dorrepaal C, et al. Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies. Eur Urol 2016; 69:361.

2. Herzog AR, Diokno AC, Brown MB, et al. Urinary incontinence as a risk factor for mortality. J Am Geriatr Soc 1994; 42:264.

3. Minassian VA, Bazi T, Stewart WF. Clinical epidemiological insights into urinary incontinence. Int Urogynecol J 2017; 28:687.

4. Brown JS, Nyberg LM, Kusek JW, et al. Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol 2003; 188:S77.

5. Milson I, Altman D, Lapitan, et al.. Epidemiology of urinary and faecal incontinence and pelvic organ prolapse. In: Incontinence, 4th ed., Abrams P, Cardozo L, Khoury S, Wein A (Eds), Health Publications Ltd., Plymouth, UK 2009. p.35.

6. Robinson D, Hanna-Mitchell A, Rantell A, et al. Are we justified in suggesting change to caffeine, alcohol, and carbonated drink intake in lower urinary tract disease? Report from the ICI-RS 2015. Neurourol Urodyn 2017; 36:876.

7. Coyne KS, Sexton CC, Irwin DE, et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008; 101:1388.

8. www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityMeasures/Downloads/Eligible-Providers-2014-Proposed-EHR-Incentive-Program-CQM.pdf (Accessed on April 06, 2015).

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ°ú¹Î¼º¹æ±¤ ÇÑÀÇ¿ø ÁÖ¸»Áø·á""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û û¶óÇѾà´ÙÀ̾îÆ® ÇÑÀÇ¿ø Ãʱ⿡ ÀâÀÚ
´ÙÀ½±Û õȣ¿ª ÇÏ´ÃüÇÑÀÇ¿ø 10¿ù ´Üµ¶¾ÞÄÝÀ̺¥Æ®
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
832 [¶óÀ²ÇÑÀÇ¿ø] 4¿ùÀ̺¥Æ®, º½À̴ϱî À̺¥Æ®ÇØ º½ 0 1,156 2021-04-01
831 ÆDZ³ ÇüÁÖÇÑÀÇ¿ø ´ÙÀ̾îÆ® È®ÂðÀÚ Å»Ãâ À̺¥Æ® 0 1,931 2021-03-26
830 º½¸ÂÀÌ ´ÙÀ̾îÆ®, ÇǺΰü¸® ÇÔ²²ÇØ¿ä~ (feat: ¼ö¸°ÇÑÀÇ¿ø ¿ÀÇÂÀ̺¥Æ®) 0 1,242 2021-03-26
829 º»ÇÑÀÇ¿ø °³¿ø À̺¥Æ® 0 1,765 2021-03-16
828 ÀϸÆÇÑÀÇ¿ø ºÎ»êÁ¡ ¸ö¸Å¼Òȯ 3¿ù À̺¥Æ® ¹× °¡°Ý 0 1,684 2021-03-16
827 ¿¬ÇÑÀÇ¿ø ù¹ø° À̺¥Æ® ½ÃÀÛÇÕ´Ï´Ù 0 1,664 2021-03-16
826 »ý±âÇÑÀÇ¿ø ½Åµµ¸²Á¡ ·¹Æ®·Î 7080 GOGO 0 1,360 2021-03-16
825 °­³²´ÙÀ̾îÆ®ÇÑÀÇ¿ø ¼±ÀÌ°íÀºÇÑÀÇ¿ø À̺¥Æ® 1 2,861 2021-03-16
824 Àá½Çµ¿ ¸¶À½¸ð¾Æ ÇÑÀÇ¿ø ¿ÀDZâ³ä ¼±¹° / À̺¥Æ® 0 1,112 2021-03-11
823 ±Ô¸²ÇÑÀÇ¿ø õ¾ÈÁ¡ 3¿ù¿¡´Â ÀÌ·± ÇýÅÃÀÌ 0 1,213 2021-03-08
822 À§·ÊÇϴþÖÇÑÀÇ¿ø °³¿ø 3ÁÖ³â ÃÖ´ëÇÒÀÎÀ̺¥Æ® 0 1,130 2021-03-08
821 ¸®¿ÂÇÑÀÇ¿ø 3¿ù À̺¥Æ® ¾çº¼ ÈäÅÍÄ¡·á 3ȸ Ư°¡ 0 1,559 2021-03-02
820 ²ÉÇÇ´Â 3¿ù! ¸®»ù º½ À̺¥Æ® 0 1,488 2021-02-27
819 ¶óÀ²ÇÑÀÇ¿ø ¼³·¹ÀÌ´Â 3¿ù º½¸ÂÀÌ À̺¥Æ® 0 1,633 2021-02-27
818 ÇÏÀ²ÇÑÀÇ¿ø 3¿ù ¾ÆÄí¾ÆÇÊ À̺¥Æ® ¾È³»µå¸³´Ï´Ù 0 1,199 2021-02-24
817 2021 »õÇظÂÀÌ À̺¥Æ®! ´ëÀü Á×µ¿ ¿Ã¹Ù¸¥ÇÑÀÇ¿ø 0 1,080 2021-02-08
816 ¼ö¿ø À̼ÒÇÑÀÇ¿ø ¼³ ¸ÂÀÌ ÇÒÀÎ À̺¥Æ® ¹× Áø·á¾È³» 0 1,050 2021-02-08
815 Âü´ÙÀÎÇÑÀÇ¿ø ¼³ ¿¬ÈÞ Áø·á ¾È³» & À̺¥Æ® 0 1,036 2021-02-08
814 °­µ¿±¸ ÂüÇÑÀÇ¿ø 2¿ù ÇÒÀÎ À̺¥Æ® ¾È³» 0 823 2021-02-08
813 È­°î¿ª ÇÑÀÇ¿ø ¸¼Àº½£365ÇÑÀÇ¿ø °¡º¸¼¼¿ä 3 939 2021-02-04
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷